This week saw major advances in agentic AI for scientific research. Causaly launched a new tool called Discover, which uses AI agents to speed up biomedical discoveries by analyzing data from multiple sources. In California, researchers at a big science meeting discussed how AI agents can help create and test scientific ideas faster than humans.

A company in Utah, Recursion Pharmaceuticals, built a supercomputer named BioHive-2 to find cancer drugs using AI agents that learn from lab experiments. Another team in Massachusetts, Plex Research, partnered with Ginkgo Bioworks to use AI agents for finding new uses for existing medicines.

Scientists also shared free online classes to teach researchers how to use AI tools like AlphaFold for predicting protein structures, which helps in drug design. These developments show how agentic AI is becoming a key helper in solving tough health problems worldwide.